Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Medtronic
Johnson and Johnson
US Department of Justice
Baxter

Generated: September 15, 2019

DrugPatentWatch Database Preview

Patent: 7,407,931

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,407,931
Title:Method of treating Crohn\'s Disease using sargramostim
Abstract: Immune stimulatory amounts of hematopoietic colony stimulating factors are administered to patients with inflammatory bowel disease. The factors include G-CSF and GM-CSF. These factors induce and maintain remission of the disease and its manifestations, whether within the intestine or without.
Inventor(s): Dieckgraefe; Brian K. (Chesterfield, MO), Korzenik; Joshua (St. Louis, MO)
Assignee: Washington University (St. Louis, MO)
Application Number:11/099,461
Patent Claims:see list of patent claims

Details for Patent 7,407,931

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Berlex Labs LEUKINE sargramostim VIAL 103362 001 1991-03-05 ➤ Sign Up Washington University (St. Louis, MO) 2020-08-11 RX search
Berlex Labs LEUKINE sargramostim VIAL 103362 002 1991-03-05 ➤ Sign Up Washington University (St. Louis, MO) 2020-08-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Federal Trade Commission
AstraZeneca
Argus Health
Daiichi Sankyo
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.